Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on October 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

LOSARTAN POTASSIUM TAB

Closed
SPE2DP-26-T-5351Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Solicitation SPE2DP-26-T-5351, issued by the DLA Troop Support Medical Supply Chain, is a request for quotations for Losartan Potassium Tablets, 25 MG. The requirement is for two bottles, with each bottle containing 90 tablets, identified by NSN 6505-01-41-44064. The product is FDA regulated and must have a non-extendable shelf life of 24 months. Delivery is required within 20 days after receipt of order to the USNS Impeccable at FPO AP 96668, with an original required delivery date of October 1, 2026. Shipping must be conducted via traceable means, and the use of parcel post is strictly prohibited. The contract mandates strict adherence to commercial packaging and packing standards, specifically ASTM D3951 for non-hazardous materials, though DLA Master List Technical and Quality Requirements take precedence. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of Wide Area WorkFlow for invoicing and compliance with various FAR and DFARS clauses, including those regarding the Buy American Act, safeguarding covered defense information, and combating trafficking in persons.

General Info

DLA request for Losartan Potassium 25MG tablets delivered to USNS Impeccable by 2026.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

UNIT 100461 BOX 1, FPO, AP, 96668, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this first18 pages · rfq
High

Read the document

Every page of every file, in your free workspace.

Read the document

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

View Full Breakdown

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • Sodium Chloride 0.9% Injection SupplierOpen now, due in 7 days
  • Supply of Surgical Detergent (Chlorhexidine Gluconate)Open now, due in 7 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
LOSARTAN POTASSIUM TABLETS
LOSARTAN POTASSIUM TABLETS, 25 MG, 90S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO Sign up to see this detail. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
UNIT ISSUE IS BOTTLE
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 BT = 90 EA
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SPE2DP-26-T-5351
SECTION B
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
XLCARE PHARMACEUTICALS INC 86SL9 P/N NDC71610-0439-60 ORGANON LLC 8X6F2 P/N NDC78206-0121-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018556924 0001 BT 2.000
NSN/MATERIAL:6505014144064
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N21906
USNS IMPECCABLE T AGOS 23
UNIT 100461 BOX 1
FPO AP 96668
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
N21906
USNS IMPECCABLE T AGOS 23
SPE2DP-26-T-5351
SECTION B
PR: 7018556924 PRLI: 0001 CONT’D
DLA VENDORS: USE VSM FOR
US
M/F: (TCN) N219066271S180
RDD: 292
PROJ: HJ5 TP 3
SUPP ADD: YA2 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 13
DIC: A4A DIST: 9B ADV: 2A FC: E5
Need Ship Date:00/00/0000 Original Required Delivery Date:10/01/2026
SPE2DP-26-T-5351 NSN/Part Number: 6505-01-414-4064 Quantity: 2 BT Purchase Request: 7018556924QTY: 2 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS